Quarterly Holdings Report
for
Fidelity® Small Cap Growth K6 Fund
October 31, 2021
SCPK6-NPRT1-1221
1.9884008.104
Common Stocks - 97.7% | |||
Shares | Value ($) | ||
COMMUNICATION SERVICES - 2.5% | |||
Media - 1.9% | |||
Integral Ad Science Holding Corp. | 179,213 | 4,403,263 | |
TechTarget, Inc. (a) | 210,360 | 19,839,052 | |
24,242,315 | |||
Wireless Telecommunication Services - 0.6% | |||
Gogo, Inc. (a) | 473,745 | 7,703,094 | |
TOTAL COMMUNICATION SERVICES | 31,945,409 | ||
CONSUMER DISCRETIONARY - 16.0% | |||
Hotels, Restaurants & Leisure - 3.5% | |||
Caesars Entertainment, Inc. (a) | 118,472 | 12,967,945 | |
Churchill Downs, Inc. | 45,034 | 10,357,820 | |
Dutch Bros, Inc. | 55,900 | 4,261,816 | |
Everi Holdings, Inc. (a)(b) | 171,574 | 4,117,776 | |
Lindblad Expeditions Holdings (a) | 788,337 | 11,785,638 | |
NeoGames SA | 50,286 | 1,868,125 | |
45,359,120 | |||
Household Durables - 2.1% | |||
GoPro, Inc. Class A (a) | 316,048 | 2,721,173 | |
Helen of Troy Ltd. (a) | 8,829 | 1,986,084 | |
Lovesac (a)(b) | 176,633 | 13,779,140 | |
M/I Homes, Inc. (a) | 41,313 | 2,365,582 | |
Sonos, Inc. (a) | 90,250 | 2,943,955 | |
Traeger, Inc. (a)(b) | 146,180 | 2,761,340 | |
26,557,274 | |||
Internet & Direct Marketing Retail - 1.8% | |||
Farfetch Ltd. Class A (a) | 62,272 | 2,441,685 | |
Overstock.com, Inc. (a) | 13,400 | 1,276,082 | |
Porch Group, Inc. Class A (a)(b) | 420,035 | 8,833,336 | |
Revolve Group, Inc. (a) | 51,590 | 3,871,314 | |
The Original BARK Co. (c) | 267,300 | 1,967,328 | |
The Original BARK Co.: | |||
warrants 8/29/25 (a) | 130,921 | 210,783 | |
Class A (a)(b) | 533,436 | 3,926,089 | |
thredUP, Inc. (a) | 22,625 | 489,605 | |
23,016,222 | |||
Leisure Products - 0.2% | |||
Callaway Golf Co. (a) | 81,300 | 2,199,165 | |
Specialty Retail - 4.7% | |||
American Eagle Outfitters, Inc. (b) | 556,283 | 13,206,158 | |
Dick's Sporting Goods, Inc. | 37,099 | 4,608,067 | |
Fanatics, Inc. Class A (c)(d) | 163,048 | 7,723,584 | |
Floor & Decor Holdings, Inc. Class A (a) | 50,485 | 6,861,921 | |
Lithia Motors, Inc. Class A (sub. vtg.) | 18,502 | 5,906,208 | |
Musti Group OYJ | 87,702 | 3,445,012 | |
Rent-A-Center, Inc. | 126,350 | 6,729,401 | |
Warby Parker, Inc. (a)(b) | 53,700 | 2,899,800 | |
Williams-Sonoma, Inc. | 46,922 | 8,714,823 | |
60,094,974 | |||
Textiles, Apparel & Luxury Goods - 3.7% | |||
Algolia, Inc. (c)(d) | 43,269 | 1,265,404 | |
Crocs, Inc. (a) | 204,359 | 32,993,766 | |
Deckers Outdoor Corp. (a) | 21,182 | 8,373,456 | |
Tapestry, Inc. | 138,787 | 5,409,917 | |
48,042,543 | |||
TOTAL CONSUMER DISCRETIONARY | 205,269,298 | ||
CONSUMER STAPLES - 2.4% | |||
Food & Staples Retailing - 1.4% | |||
BJ's Wholesale Club Holdings, Inc. (a) | 319,027 | 18,643,938 | |
Food Products - 0.5% | |||
Darling Ingredients, Inc. (a) | 70,055 | 5,921,049 | |
Personal Products - 0.5% | |||
The Beauty Health Co. (a)(b) | 251,111 | 6,898,019 | |
TOTAL CONSUMER STAPLES | 31,463,006 | ||
ENERGY - 2.1% | |||
Energy Equipment & Services - 0.1% | |||
Fluence Energy, Inc. | 22,800 | 810,996 | |
Oil, Gas & Consumable Fuels - 2.0% | |||
Antero Resources Corp. (a) | 498,806 | 9,911,275 | |
Enviva Partners LP | 134,313 | 8,993,598 | |
Genesis Energy LP | 223,016 | 2,430,874 | |
Range Resources Corp. (a) | 202,813 | 4,729,599 | |
26,065,346 | |||
TOTAL ENERGY | 26,876,342 | ||
FINANCIALS - 6.2% | |||
Banks - 1.3% | |||
Glacier Bancorp, Inc. | 68,415 | 3,782,665 | |
Hilltop Holdings, Inc. | 1,095 | 38,807 | |
PacWest Bancorp | 60,486 | 2,871,270 | |
Signature Bank | 14,969 | 4,458,068 | |
Silvergate Capital Corp. (a) | 29,215 | 4,575,653 | |
Starling Bank Ltd. Series D (a)(c)(d) | 391,300 | 693,142 | |
16,419,605 | |||
Capital Markets - 2.6% | |||
Impax Asset Management Group PLC | 124,357 | 1,865,269 | |
Lazard Ltd. Class A | 88,531 | 4,337,134 | |
LPL Financial | 32,982 | 5,409,708 | |
Morningstar, Inc. | 20,362 | 6,449,664 | |
Perella Weinberg Partners (c) | 457,262 | 6,419,958 | |
StepStone Group, Inc. Class A | 186,244 | 8,749,743 | |
33,231,476 | |||
Consumer Finance - 0.2% | |||
OneMain Holdings, Inc. | 63,422 | 3,349,316 | |
Insurance - 1.9% | |||
American Financial Group, Inc. | 58,889 | 8,011,260 | |
Assurant, Inc. | 50,662 | 8,172,287 | |
BRP Group, Inc. (a) | 209,236 | 7,637,114 | |
HCI Group, Inc. | 5,200 | 696,852 | |
24,517,513 | |||
Thrifts & Mortgage Finance - 0.2% | |||
Meta Financial Group, Inc. | 44,221 | 2,451,612 | |
TOTAL FINANCIALS | 79,969,522 | ||
HEALTH CARE - 27.6% | |||
Biotechnology - 12.4% | |||
4D Molecular Therapeutics, Inc. (b) | 59,180 | 1,422,095 | |
ADC Therapeutics SA (a) | 56,818 | 1,647,154 | |
Agios Pharmaceuticals, Inc. (a) | 68,645 | 3,226,315 | |
Allakos, Inc. (a) | 57,676 | 5,801,052 | |
Allovir, Inc. (a)(b) | 114,617 | 2,751,954 | |
ALX Oncology Holdings, Inc. (a) | 53,289 | 2,986,316 | |
Ambrx Biopharma, Inc. ADR (b) | 15,480 | 195,048 | |
Annexon, Inc. (a)(b) | 46,669 | 761,171 | |
Argenx SE ADR (a) | 17,497 | 5,283,394 | |
Ascendis Pharma A/S sponsored ADR (a) | 53,351 | 8,088,545 | |
Avid Bioservices, Inc. (a) | 130,848 | 4,014,417 | |
Bicycle Therapeutics PLC ADR (a) | 33,600 | 1,727,040 | |
Biohaven Pharmaceutical Holding Co. Ltd. (a) | 22,922 | 3,262,259 | |
Bolt Biotherapeutics, Inc. | 93,804 | 1,227,894 | |
Celldex Therapeutics, Inc. (a) | 105,637 | 4,493,798 | |
Century Therapeutics, Inc. (b) | 80,986 | 1,819,755 | |
Cytokinetics, Inc. (a) | 193,792 | 6,765,279 | |
Erasca, Inc. | 121,139 | 2,396,129 | |
Exelixis, Inc. (a) | 131,807 | 2,835,169 | |
Forma Therapeutics Holdings, Inc. (a) | 86,521 | 1,605,830 | |
Graphite Bio, Inc. | 84,810 | 1,080,479 | |
Gritstone Bio, Inc. (a) | 106,772 | 1,173,424 | |
Halozyme Therapeutics, Inc. (a) | 68,148 | 2,594,394 | |
Immunocore Holdings PLC ADR (b) | 62,225 | 2,396,907 | |
ImmunoGen, Inc. (a) | 235,239 | 1,418,491 | |
Instil Bio, Inc. (a) | 207 | 4,217 | |
Instil Bio, Inc. (e) | 277,674 | 5,656,219 | |
Janux Therapeutics, Inc. (b) | 64,262 | 1,564,780 | |
Keros Therapeutics, Inc. (a) | 48,507 | 2,023,712 | |
Kura Oncology, Inc. (a) | 142,980 | 2,347,732 | |
Kymera Therapeutics, Inc. (a) | 56,405 | 3,321,126 | |
Monte Rosa Therapeutics, Inc. (b) | 103,541 | 2,428,036 | |
Morphic Holding, Inc. (a) | 84,604 | 4,864,730 | |
Natera, Inc. (a) | 41,998 | 4,811,711 | |
Nuvalent, Inc. | 124,141 | 2,881,126 | |
Passage Bio, Inc. (a)(b) | 113,955 | 993,688 | |
Prelude Therapeutics, Inc. (a)(b) | 134,262 | 2,360,326 | |
ProQR Therapeutics BV (a)(b) | 683,758 | 5,278,612 | |
Protagonist Therapeutics, Inc. (a) | 143,649 | 4,476,103 | |
PTC Therapeutics, Inc. (a) | 96,578 | 3,663,204 | |
Relay Therapeutics, Inc. (a) | 210,577 | 7,001,685 | |
Repare Therapeutics, Inc. (a)(b) | 101,197 | 2,530,937 | |
Revolution Medicines, Inc. (a) | 94,181 | 2,771,747 | |
Shattuck Labs, Inc. | 24,521 | 473,255 | |
Stoke Therapeutics, Inc. (a) | 23,100 | 527,373 | |
Tango Therapeutics, Inc. (c) | 113,500 | 1,457,340 | |
Taysha Gene Therapies, Inc. (a) | 26,643 | 416,697 | |
Tenaya Therapeutics, Inc. (a) | 152,945 | 3,932,216 | |
TG Therapeutics, Inc. (a) | 192,814 | 6,019,653 | |
Tyra Biosciences, Inc. | 136,942 | 3,066,131 | |
United Therapeutics Corp. (a) | 26,449 | 5,045,411 | |
Vericel Corp. (a)(b) | 57,912 | 2,665,110 | |
Verve Therapeutics, Inc. | 61,326 | 2,844,913 | |
Xenon Pharmaceuticals, Inc. (a) | 78,313 | 2,439,450 | |
158,841,549 | |||
Health Care Equipment & Supplies - 5.4% | |||
Axonics Modulation Technologies, Inc. (a) | 88,560 | 6,495,876 | |
CryoPort, Inc. (a)(b) | 50,961 | 4,155,360 | |
Envista Holdings Corp. (a) | 179,234 | 7,008,049 | |
Figs, Inc. Class A (a)(b) | 65,700 | 2,208,177 | |
Globus Medical, Inc. (a) | 48,819 | 3,767,362 | |
Inogen, Inc. (a) | 42,745 | 1,694,839 | |
Insulet Corp. (a) | 56,024 | 17,368,560 | |
Integer Holdings Corp. (a) | 60,706 | 5,464,754 | |
Minerva Surgical, Inc. | 159,805 | 1,495,775 | |
Neuronetics, Inc. (a) | 174,630 | 908,076 | |
NeuroPace, Inc. (a)(b) | 171,877 | 2,605,655 | |
OrthoPediatrics Corp. (a) | 61,253 | 4,359,376 | |
PAVmed, Inc. (a)(b) | 228,326 | 1,239,810 | |
Pulmonx Corp. (b) | 71,333 | 2,776,994 | |
TransMedics Group, Inc. (a) | 128,134 | 3,514,716 | |
ViewRay, Inc. (a) | 639,574 | 4,675,286 | |
69,738,665 | |||
Health Care Providers & Services - 3.8% | |||
Acadia Healthcare Co., Inc. (a) | 130,594 | 8,096,828 | |
Accolade, Inc. (a) | 27,261 | 1,084,715 | |
agilon health, Inc. (a) | 111,000 | 2,719,500 | |
Guardant Health, Inc. (a) | 9,200 | 1,074,468 | |
LifeStance Health Group, Inc. | 146,678 | 1,757,202 | |
Molina Healthcare, Inc. (a) | 24,308 | 7,188,362 | |
Oak Street Health, Inc. (a) | 44,723 | 2,112,267 | |
Option Care Health, Inc. (a) | 261,006 | 7,133,294 | |
R1 RCM, Inc. (a) | 405,484 | 8,799,003 | |
Signify Health, Inc. (b) | 97,564 | 1,567,853 | |
Surgery Partners, Inc. (a) | 102,386 | 4,212,160 | |
The Joint Corp. (a) | 33,522 | 2,932,505 | |
48,678,157 | |||
Health Care Technology - 2.2% | |||
Certara, Inc. | 124,450 | 5,141,030 | |
Definitive Healthcare Corp. | 9,903 | 397,506 | |
Evolent Health, Inc. (a) | 117,727 | 3,445,869 | |
Health Catalyst, Inc. (a) | 79,164 | 4,167,193 | |
Inspire Medical Systems, Inc. (a) | 21,124 | 5,694,608 | |
OptimizeRx Corp. (a)(b) | 21,900 | 2,117,730 | |
Phreesia, Inc. (a) | 67,101 | 4,733,305 | |
Schrodinger, Inc. (a) | 42,988 | 2,346,285 | |
28,043,526 | |||
Life Sciences Tools & Services - 2.9% | |||
10X Genomics, Inc. (a) | 38,607 | 6,226,151 | |
Absci Corp. | 77,448 | 1,136,162 | |
Absci Corp. | 32,701 | 455,737 | |
Charles River Laboratories International, Inc. (a) | 12,273 | 5,506,650 | |
Maravai LifeSciences Holdings, Inc. | 99,157 | 4,193,350 | |
Nanostring Technologies, Inc. (a) | 93,065 | 4,495,040 | |
Olink Holding AB ADR (a)(b) | 163,639 | 5,262,630 | |
Syneos Health, Inc. (a) | 110,050 | 10,272,067 | |
Veterinary Emergency Group LLC Class A (c)(d)(f) | 4,700 | 151,078 | |
37,698,865 | |||
Pharmaceuticals - 0.9% | |||
Arvinas Holding Co. LLC (a) | 27,576 | 2,387,530 | |
Cyteir Therapeutics, Inc. | 64,262 | 1,150,932 | |
Edgewise Therapeutics, Inc. (a) | 118,512 | 1,955,448 | |
Fulcrum Therapeutics, Inc. (a) | 22,462 | 497,309 | |
Ikena Oncology, Inc. (a) | 23,555 | 253,216 | |
Ikena Oncology, Inc. (e) | 114,928 | 1,235,476 | |
NGM Biopharmaceuticals, Inc. (a) | 49,300 | 910,571 | |
Ocular Therapeutix, Inc. (a) | 158,244 | 1,050,740 | |
Pharvaris BV (b) | 121,653 | 2,158,124 | |
Theseus Pharmaceuticals, Inc. | 22,200 | 380,064 | |
11,979,410 | |||
TOTAL HEALTH CARE | 354,980,172 | ||
INDUSTRIALS - 13.9% | |||
Aerospace & Defense - 0.5% | |||
BWX Technologies, Inc. | 111,165 | 6,307,502 | |
Air Freight & Logistics - 0.4% | |||
Hub Group, Inc. Class A (a) | 69,162 | 5,434,058 | |
Building Products - 2.9% | |||
Builders FirstSource, Inc. (a) | 283,114 | 16,497,053 | |
Resideo Technologies, Inc. (a) | 149,426 | 3,684,845 | |
Simpson Manufacturing Co. Ltd. | 46,805 | 4,965,542 | |
The AZEK Co., Inc. (a) | 192,910 | 7,077,868 | |
UFP Industries, Inc. | 67,933 | 5,558,957 | |
37,784,265 | |||
Commercial Services & Supplies - 0.3% | |||
Driven Brands Holdings, Inc. | 100,503 | 3,263,332 | |
Construction & Engineering - 1.0% | |||
Quanta Services, Inc. | 22,329 | 2,708,061 | |
Willscot Mobile Mini Holdings (a) | 302,749 | 10,520,528 | |
13,228,589 | |||
Electrical Equipment - 1.9% | |||
Acuity Brands, Inc. | 21,444 | 4,405,241 | |
nVent Electric PLC | 51,618 | 1,829,858 | |
Regal Rexnord Corp. | 33,967 | 5,174,193 | |
Sensata Technologies, Inc. PLC (a) | 87,244 | 4,807,144 | |
Shoals Technologies Group, Inc. | 110,802 | 3,433,754 | |
Sunrun, Inc. (a) | 79,028 | 4,558,335 | |
24,208,525 | |||
Machinery - 1.8% | |||
Chart Industries, Inc. (a) | 22,527 | 3,998,993 | |
Crane Co. | 97,432 | 10,062,777 | |
ITT, Inc. | 60,352 | 5,677,313 | |
Kornit Digital Ltd. (a) | 17,153 | 2,869,354 | |
22,608,437 | |||
Professional Services - 3.9% | |||
Alight, Inc. Class A (a) | 636,229 | 6,922,172 | |
ASGN, Inc. (a) | 74,309 | 8,891,815 | |
CACI International, Inc. Class A (a) | 26,719 | 7,685,453 | |
First Advantage Corp. | 65,976 | 1,233,751 | |
KBR, Inc. | 362,558 | 15,386,962 | |
Korn Ferry | 73,798 | 5,697,944 | |
Sterling Check Corp. | 45,000 | 965,250 | |
TriNet Group, Inc. (a) | 29,270 | 2,963,588 | |
49,746,935 | |||
Trading Companies & Distributors - 1.2% | |||
Applied Industrial Technologies, Inc. | 56,921 | 5,548,659 | |
Beacon Roofing Supply, Inc. (a) | 108,444 | 5,733,434 | |
Custom Truck One Source, Inc. Class A (a)(b) | 461,232 | 4,174,150 | |
15,456,243 | |||
TOTAL INDUSTRIALS | 178,037,886 | ||
INFORMATION TECHNOLOGY - 20.5% | |||
Communications Equipment - 0.1% | |||
Calix, Inc. (a) | 19,132 | 1,197,472 | |
Electronic Equipment & Components - 0.7% | |||
Fabrinet (a) | 59,819 | 5,742,624 | |
TD SYNNEX Corp. | 34,517 | 3,624,285 | |
9,366,909 | |||
IT Services - 3.4% | |||
Concentrix Corp. | 41,618 | 7,394,686 | |
Digitalocean Holdings, Inc. (a) | 58,221 | 5,681,787 | |
Dlocal Ltd. (b) | 83,698 | 4,060,190 | |
Flywire Corp. (a) | 40,405 | 1,916,813 | |
Genpact Ltd. | 174,761 | 8,624,455 | |
Nuvei Corp. (a)(e) | 43,379 | 5,213,472 | |
Perficient, Inc. (a) | 39,013 | 4,822,007 | |
Thoughtworks Holding, Inc. | 91,300 | 2,637,657 | |
Verra Mobility Corp. (a) | 240,687 | 3,581,423 | |
43,932,490 | |||
Semiconductors & Semiconductor Equipment - 4.3% | |||
AEHR Test Systems (a) | 74,500 | 1,685,190 | |
Ambarella, Inc. (a) | 31,900 | 5,927,977 | |
Cirrus Logic, Inc. (a) | 75,171 | 6,074,569 | |
eMemory Technology, Inc. | 54,000 | 4,460,406 | |
Nova Ltd. (a) | 39,541 | 4,294,943 | |
Semtech Corp. (a) | 129,647 | 11,023,884 | |
SiTime Corp. (a) | 79,238 | 20,989,354 | |
54,456,323 | |||
Software - 11.4% | |||
Alkami Technology, Inc. (a)(b) | 171,964 | 5,158,920 | |
Amplitude, Inc. (a) | 69,726 | 5,179,945 | |
AvidXchange Holdings, Inc. | 102,400 | 2,276,352 | |
Blend Labs, Inc. | 157,910 | 2,289,695 | |
CCC Intelligent Solutions Holdings, Inc. (c) | 10,832 | 129,767 | |
Couchbase, Inc. (b) | 9,769 | 393,886 | |
CyberArk Software Ltd. (a)(b) | 63,488 | 11,434,824 | |
DoubleVerify Holdings, Inc. (a)(b) | 45,944 | 1,816,166 | |
DoubleVerify Holdings, Inc. (e) | 64,933 | 2,566,801 | |
Dynatrace, Inc. (a) | 119,934 | 8,995,050 | |
Elastic NV (a) | 62,989 | 10,929,221 | |
Fortnox AB | 24,678 | 1,747,115 | |
Latch, Inc. (a)(b) | 126,364 | 1,123,376 | |
Lightspeed Commerce, Inc. (Canada) (a) | 63,683 | 6,207,240 | |
Matterport, Inc. (a) | 57,500 | 1,290,875 | |
Matterport, Inc. (c) | 12,700 | 285,115 | |
Monday.com Ltd. (b) | 12,041 | 4,477,205 | |
Rapid7, Inc. (a) | 116,561 | 15,007,229 | |
SentinelOne, Inc. | 58,461 | 3,881,810 | |
Similarweb Ltd. (a)(b) | 196,899 | 3,788,337 | |
Sprout Social, Inc. (a) | 87,579 | 11,182,087 | |
Stronghold Digital Mining, Inc. Class A | 43,500 | 1,194,510 | |
TECSYS, Inc. | 133,452 | 6,037,474 | |
Telos Corp. | 256,152 | 6,636,898 | |
Tenable Holdings, Inc. (a) | 264,004 | 14,058,213 | |
Upsales Technology AB (a) | 51,896 | 507,599 | |
WalkMe Ltd. | 166,066 | 4,211,434 | |
Workiva, Inc. (a) | 46,337 | 6,929,698 | |
Xperi Holding Corp. | 61,278 | 1,098,102 | |
Yext, Inc. (a) | 448,356 | 5,644,802 | |
146,479,746 | |||
Technology Hardware, Storage & Peripherals - 0.6% | |||
Avid Technology, Inc. (a) | 91,158 | 2,610,765 | |
Seagate Technology Holdings PLC | 53,877 | 4,798,824 | |
7,409,589 | |||
TOTAL INFORMATION TECHNOLOGY | 262,842,529 | ||
MATERIALS - 3.7% | |||
Chemicals - 1.9% | |||
Element Solutions, Inc. | 271,351 | 6,162,381 | |
The Chemours Co. LLC | 160,181 | 4,488,272 | |
Trinseo PLC | 36,683 | 2,056,449 | |
Valvoline, Inc. | 361,870 | 12,289,105 | |
24,996,207 | |||
Construction Materials - 0.4% | |||
Eagle Materials, Inc. | 32,812 | 4,867,988 | |
Containers & Packaging - 0.7% | |||
Ardagh Metal Packaging SA (c) | 364,084 | 3,586,227 | |
Avery Dennison Corp. | 24,560 | 5,347,203 | |
8,933,430 | |||
Metals & Mining - 0.7% | |||
Iluka Resources Ltd. | 589,956 | 4,171,667 | |
Lynas Rare Earths Ltd. (a) | 761,175 | 4,197,113 | |
8,368,780 | |||
TOTAL MATERIALS | 47,166,405 | ||
REAL ESTATE - 1.9% | |||
Equity Real Estate Investment Trusts (REITs) - 0.7% | |||
Rexford Industrial Realty, Inc. | 61,048 | 4,102,426 | |
Terreno Realty Corp. | 63,932 | 4,675,347 | |
8,777,773 | |||
Real Estate Management & Development - 1.2% | |||
Compass, Inc. (a) | 599,455 | 7,852,861 | |
Jones Lang LaSalle, Inc. (a) | 28,082 | 7,251,615 | |
15,104,476 | |||
TOTAL REAL ESTATE | 23,882,249 | ||
UTILITIES - 0.9% | |||
Independent Power and Renewable Electricity Producers - 0.9% | |||
NextEra Energy Partners LP | 55,972 | 4,830,384 | |
Sunnova Energy International, Inc. (a)(b) | 156,228 | 6,961,520 | |
11,791,904 | |||
TOTAL COMMON STOCKS (Cost $921,598,906) | 1,254,224,722 | ||
Convertible Preferred Stocks - 2.2% | |||
Shares | Value ($) | ||
CONSUMER DISCRETIONARY - 0.3% | |||
Internet & Direct Marketing Retail - 0.3% | |||
Reddit, Inc. Series F (c)(d) | 46,800 | 2,891,978 | |
Textiles, Apparel & Luxury Goods - 0.0% | |||
Algolia SAS Series D (c)(d) | 9,900 | 289,526 | |
TOTAL CONSUMER DISCRETIONARY | 3,181,504 | ||
HEALTH CARE - 0.5% | |||
Biotechnology - 0.4% | |||
Bright Peak Therapeutics AG Series B (c)(d) | 199,331 | 778,587 | |
Caris Life Sciences, Inc. Series D (c)(d) | 144,435 | 1,169,924 | |
Sonoma Biotherapeutics, Inc.: | |||
Series B (c)(d) | 438,013 | 1,016,190 | |
Series B1 (c)(d) | 233,603 | 541,959 | |
T-Knife Therapeutics, Inc. Series B (c)(d) | 201,583 | 1,162,892 | |
Treeline Biosciences Series A (c)(d) | 21,246 | 166,303 | |
4,835,855 | |||
Health Care Providers & Services - 0.1% | |||
Boundless Bio, Inc. Series B (c)(d) | 682,407 | 921,249 | |
Health Care Technology - 0.0% | |||
Wugen, Inc. Series B (c)(d) | 59,982 | 465,154 | |
TOTAL HEALTH CARE | 6,222,258 | ||
INDUSTRIALS - 0.6% | |||
Construction & Engineering - 0.4% | |||
Beta Technologies, Inc. Series A (c)(d) | 62,752 | 4,597,839 | |
Road & Rail - 0.2% | |||
Convoy, Inc. Series D (a)(c)(d) | 192,936 | 3,295,347 | |
TOTAL INDUSTRIALS | 7,893,186 | ||
INFORMATION TECHNOLOGY - 0.8% | |||
Communications Equipment - 0.3% | |||
Astranis Space Technologies Corp. Series C (c)(d) | 125,912 | 3,206,979 | |
IT Services - 0.5% | |||
Yanka Industries, Inc.: | |||
Series E (a)(c)(d) | 191,029 | 6,089,393 | |
Series F (c)(d) | 28,989 | 924,077 | |
7,013,470 | |||
Software - 0.0% | |||
Skyryse, Inc. Series B (c)(d) | 12,000 | 296,160 | |
TOTAL INFORMATION TECHNOLOGY | 10,516,609 | ||
TOTAL CONVERTIBLE PREFERRED STOCKS (Cost $22,901,789) | 27,813,557 | ||
Convertible Bonds - 0.0% | |||
Principal Amount (g) | Value ($) | ||
CONSUMER STAPLES - 0.0% | |||
Food & Staples Retailing - 0.0% | |||
The Real Good Food Co. LLC 1% (c)(h) (Cost $440,000) | 440,000 | 440,000 | |
Money Market Funds - 5.4% | |||
Shares | Value ($) | ||
Fidelity Securities Lending Cash Central Fund 0.06% (i)(j) (Cost $69,982,212) | 69,975,214 | 69,982,212 | |
TOTAL INVESTMENT IN SECURITIES - 105.3% (Cost $1,014,922,907) | 1,352,460,491 |
NET OTHER ASSETS (LIABILITIES) - (5.3)% | (68,425,492) |
NET ASSETS - 100.0% | 1,284,034,999 |
Legend
(a) | Non-income producing |
(b) | Security or a portion of the security is on loan at period end. |
(c) | Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $51,932,500 or 4.0% of net assets. |
(d) | Level 3 security |
(e) | Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $14,671,968 or 1.1% of net assets. |
(f) | Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes. |
(g) | Amount is stated in United States dollars unless otherwise noted. |
(h) | Security is perpetual in nature with no stated maturity date. |
(i) | Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request. |
(j) | Investment made with cash collateral received from securities on loan. |
Additional information on each restricted holding is as follows: | ||
Security | Acquisition Date | Acquisition Cost ($) |
Algolia SAS Series D | 7/23/21 | 289,526 |
Algolia, Inc. | 10/27/21 | 1,265,404 |
Ardagh Metal Packaging SA | 2/22/21 | 3,640,840 |
Astranis Space Technologies Corp. Series C | 3/19/21 | 2,760,108 |
Beta Technologies, Inc. Series A | 4/09/21 | 4,597,839 |
Boundless Bio, Inc. Series B | 4/23/21 | 921,249 |
Bright Peak Therapeutics AG Series B | 5/14/21 | 778,587 |
Caris Life Sciences, Inc. Series D | 5/11/21 | 1,169,924 |
CCC Intelligent Solutions Holdings, Inc. | 2/02/21 | 108,320 |
Convoy, Inc. Series D | 10/30/19 | 2,612,353 |
Fanatics, Inc. Class A | 8/13/20 - 3/22/21 | 2,891,600 |
Matterport, Inc. | 2/08/21 | 127,000 |
Perella Weinberg Partners | 12/29/20 | 4,572,620 |
Reddit, Inc. Series F | 8/11/21 | 2,891,978 |
Skyryse, Inc. Series B | 10/21/21 | 296,160 |
Sonoma Biotherapeutics, Inc. Series B | 7/26/21 | 865,645 |
Sonoma Biotherapeutics, Inc. Series B1 | 7/26/21 | 692,516 |
Starling Bank Ltd. Series D | 6/18/21 | 699,600 |
T-Knife Therapeutics, Inc. Series B | 6/30/21 | 1,162,892 |
Tango Therapeutics, Inc. | 4/13/21 | 1,135,000 |
The Original BARK Co. | 12/17/20 | 2,673,000 |
The Real Good Food Co. LLC 1% | 5/07/21 | 440,000 |
Treeline Biosciences Series A | 7/30/21 | 166,303 |
Veterinary Emergency Group LLC Class A | 9/16/21 | 151,078 |
Wugen, Inc. Series B | 7/09/21 | 465,154 |
Yanka Industries, Inc. Series E | 5/15/20 | 2,307,478 |
Yanka Industries, Inc. Series F | 4/08/21 | 924,077 |
Affiliated Central Funds
Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.
Affiliate | Value, beginning of period ($) | Purchases ($) | Sales Proceeds ($) | Dividend Income ($) | Realized Gain (loss) ($) | Change in Unrealized appreciation (depreciation) ($) | Value, end of period ($) | %ownership, end of period |
Fidelity Cash Central Fund 0.06% | 4,152,847 | 111,649,468 | 115,802,315 | 1,170 | - | - | - | 0.0% |
Fidelity Securities Lending Cash Central Fund 0.06% | 107,112,980 | 102,495,319 | 139,626,087 | 153,232 | - | - | 69,982,212 | 0.2% |
Total | 111,265,827 | 214,144,787 | 255,428,402 | 154,402 | - | - | 69,982,212 |
Amounts in the income column in the above table include any capital gain distributions from underlying funds.
Amount for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.
Investment Valuation
Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events, changes in interest rates and credit quality. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee.
The inputs to valuation techniques used to value investments are categorized into a disclosure hierarchy consisting of three levels as shown below:
Level 1 - quoted prices in active markets for identical investments
Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)
Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)
Valuation techniques used to value investments by major category are as follows:
Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For any foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.
Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing vendors or from brokers who make markets in such securities. Convertible Bonds are valued by pricing vendors who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing vendors. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.
Investments in any open-end mutual funds are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.
Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy.
For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.
The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.
Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.